Glutathione bulk powder raw material - NMN suppliers & manufacturers in China.
Many heart patients, especially those with heart failure, are taking coenzyme Q10 for a long time. From 1976 to 1998, the main topics of at least 10 large international academic conferences were researches on the biochemical and clinical effects of coenzyme Q10.
Yellow to orange-yellow powder
Loss on drying
Not more than 1%
Not more than 10ppm
24 months when properly stored.
In these academic seminars, more than 200 scientists and clinicians from 18 countries who have been studying CoQ10 for more than 10 years have published more than 350 research papers in total. After their research and clinical validation, statistics show that patients with congestive heart failure and other cardiovascular diseases have significantly lower levels of coenzyme Q10 in their heart tissue than healthy people. And daily supplementation of 100mg or more of coenzyme Q10 can significantly improve this situation.
The American "Journal of Cardiology" once reported that heart patients who took coenzyme Q10 alone or combined it with other drugs lived an average of 3 years longer than patients who did not take coenzyme Q10. One of the reasons coenzyme Q10 is known as a heart-protecting supplement is because it is so effective in treating congestive heart failure.
Researchers in Japan have found that supplementation with coenzyme Q10 immediately before or immediately after cardiopulmonary bypass is beneficial in preventing reperfusion injury, a common complication in cardiac surgery. Supplementation with CoQ10 has been found to be beneficial in patients with chronic stable angina, mitral valve prolapse and cardiac arrhythmias. Coenzyme Q10 has proven useful in the treatment of various cardiomyopathies, diseases of the heart muscle that reduce its pumping ability. Studies have shown that small supplements for 12 months, 100mg/d, can lead to better pumping capacity (increased rejection fraction), increased muscle strength and improved breathing. Therefore, CoQ10 has been approved in Japan for the treatment of congestive heart failure, ischemic heart disease, rheumatic heart disease and irregular heartbeat.
During the 1980s and 1990s, the international medical community spent more than 20 years, conducted thousands of public and seven large-scale long-term double-blind clinical trials, established and confirmed that coenzyme Q10 is particularly effective in the treatment of heart disease. is effective and safe in the treatment of heart failure.